|
|
Rating: 0.0 (0 Votes cast)
Permalink
Embed Code
DescriptionWelcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera Aegerion Pharmaceuticals Incorporated - symbol AEGR - provided a clinical update on its lomitapide. Aegerion reported that the 78-week data from its pivotal Phase III clinical trial is consistent with data previously reported at the... TagsAegerion, Aegerion, Pharmaceuticals, AEGR, bad, cholesterol, genetic, lipid, disorders, LDL-C, LDL-C, cholesterol, lipid, disorders, lomitapide, low, density, lipopr
|
Add comment